The microplate reader market was valued at US$ 534.5 million in 2019 and is projected to reach US$ 704.4 million by 2027; it is expected to grow at a CAGR of 3.6% during 2020–2027. The market is attributed to increasing research and development in the pharmaceuticals industry, and escalating incidence of infectious diseases. However, high cost of advanced microplate reader is a key factor hindering the market growth.
Pharmaceutical R&D is gaining traction worldwide owing to the rising focus on drug discovery.The US biopharmaceuticals industry has been at the forefront of the development of new therapeutics.
As per the Pharmaceutical Research and Manufacturers of America (PhRMA), the biopharmaceutical industry invested US$ 83 billion in R&D in 2019.The increasing demand for new approaches in drug discovery is bolstering the growth of microplate readers.
Various companies are developing microplate readers for the drug discovery process to make the research process easier and faster. BioTek Instruments, Inc. offers Synergy HT, a unique multi-detection microplate reader for HTS and drug discovery. Moreover, pharmaceutical companies are investing heavily in the drug discovery, gene sequencing, and target protein development. Understanding the protein–drug interactions is a crucial and vital part of the drug discovery process. Furthermore, the development of personalized medicines is leading to increasing demand for genetic studies, which, in turn, is likely to contribute to the growth of the microplate reader market. Precision medicine utilizes genomic information of an individual to offer targeted treatment for a particular indication.The increasing prevalence of chronic diseases has increased the demand for biologics, drugs for orphan diseases, and personalized medicines.
For instance, in 2019, the FDA approved 12 personalized medications to address the root cause of diseases and to integrate precision medicine with clinical care.Also, increasing government efforts are strengthening personalized medicine research.
In February 2020, the National Human Genome Research Institute (NHGRI) announced a new precision medicine and genomics program to focus on bringing innovations in genomics and informatics tools for better disease diagnosis and treatment. Advancements in genomics and proteomics is a key trend driving the growth of the microplate reader market.
The microplate reader market is witnessing considerable growth amid the COVID-19 pandemic.Surge in research and development, and diagnostics activities pertaining to the novel coronavirus is a key factor propelling the market growth.
In addition, emphasis on vaccine development across the world is also estimated to offer lucrative opportunities for the market growth.
On the basis of type, the microplate reader market is segmented into single-mode microplate readers and multi-mode microplate readers.Single-mode microplate readers segment is further segmented into absorbance plate readers, fluorescence plate readers, and luminescence plate readers.
Furthermore, the multi-mode microplate reader segment is subsegmented into filter-based readers, monochromator-based readers, and hybrid readers. The single-mode microplate readers segment held a larger share of the market in 2019; however, the multi-mode microplate reader segment is projected to register a higher CAGR in the market during the forecast period.
The microplate reader market, by application, is segmented into genomics and proteomics research, drug discovery, clinical diagnostics, and other applications. The drug discovery segment held the largest share of the market in 2019, and the clinical diagnostics segment is estimated to register the highest CAGR in the market during 2020–2027.
On the basis of end user, the microplate reader market is segmented into hospitals and diagnostic laboratories, biotechnology and pharmaceutical companies, and research and academic institutes. The biotechnology and pharmaceuticals companies segment held the largest share of the market in 2019, and it is further estimated to register the highest CAGR during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), National Health Service (NHS), and Centers for Disease Control and Prevention (CDC) are among the major primary and secondary sources referred to while preparing this report.
Our reports have been used by over 10K customers, including:
Chemotherapy Induced Nausea and Vomiting (Other Diseases) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Nausea and Vomiting - Drugs in Development, 2021, provides an overview of the Chemotherapy Induced Nausea and Vomiting...
The Peptide Therapeutics Market is valued at approximately USD 28,510.60 million in 2020 and is expected to witness a revenue of USD 51,360.30 million in 2026, with a CAGR of 9.66% over the forecast period (2021-2026). Novel peptides are being developed and repurposed as therapeutics for the treatment of COVID-19. Globally, researchers...
The Global Electronic Clinical Outcome Assessment Solution Market (eCOA) size is expected to reach $2.4 billion by 2026, rising at a market growth of 19% CAGR during the forecast period. Electronic clinical outcome assessment (eCOA) refers to a system that is capable of measuring mental state, patient symptom, and the prognosis of a disease....
The mass spectrometry market size is expected to grow from an estimated USD 4.1 billion in 2020 to USD 5.6 billion by 2025, at a CAGR of 6.5%. Increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and growing...
Community Acquired Pneumonia (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Community Acquired Pneumonia - Drugs in Development, 2021, provides an overview of the Community Acquired Pneumonia (Infectious Disease) pipeline...
The onychomycosis market estimated to be valued at USD USD 2730.72 million in 2020 and is expected to reach approximately USD 3781.42 million in 2026, registering a CAGR of nearly 5.75% during the forecast period. Prior to the COVID-19 pandemic, clinical examination, dermoscopy, and mycological examination were recommended for all patients...
The global pharmaceutical membrane filtration market is estimated to grow from USD 5.8 billion in 2020 to reach USD 10.2 billion by 2025, at a CAGR of 12.0% during the forecast period. The rising adoption of single-use technologies, rapid growth in the pharmaceutical and biopharmaceutical industries, and the growing demand for nanofiltration...
The Global Pharmaceutical CDMO Market was valued USD 160.12 billion in 2020, and it is expected to reach USD 236.61 billion by 2026, registering a CAGR of 6.5%, during the period of forecast period (2021-2026). The CMO/CDMO service sector is uniquely positioned to address some of the challenges that drug developers are facing amid the COVID-19...
The cooler box market is estimated to be valued at USD 4.6 billion in 2020 and is projected to reach USD 8.1 billion by 2025, at a CAGR of 12.1% from 2020 to 2025 Growth in the pharmaceutical industry, ongoing COVID-19 vaccination drives, transportation of processed and fresh fruits, vegetables, dairy products, and other perishable food products...
Crude Oil Price
Gross Domestic Product
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.